A Positron Emission Tomography (PET) scanner is a medical imaging device that allows doctors to view metabolic and functional processes in the body, often at the cellular level. It detects pairs of gamma rays emitted when a small amount of a radioactive substance, typically a radiotracer, is injected into the body. Usually, this substance is a kind of glucose or another positron-releasing decaying molecule.
Global Positron Emission Tomography (PET) Scanner Market Driving Factors and Challenges
Driving Factors- Some of the primary factors include the increasing need for PET analysis in radiopharmaceuticals, the discernible shift towards image-guided therapy, and advancements in PET imaging technologies for cancer and complex diagnostic applications. As the healthcare sector grows, it is expected that implementing these developments would lead to a rise in the use of PET scanners across a range of medical specializations.
Increased government financing for accelerating medication development processes while preserving patient safety is driving market growth. For instance, the FDA's Real-World Evidence (RWE) program promotes the use of real-world data in clinical trials, which can lead to faster approvals and more efficient study designs.
Challenges- Some of the primary drivers include the rise in image-guided therapeutics, the increasing requirement for PET analysis in radiopharmaceuticals, and advancements in PET imaging technologies for cancer and sophisticated diagnostic applications. Incorporating these developments is expected to boost PET scanner usage across a range of medical specialties as the healthcare sector grows.
Growing government financing to speed up drug development processes while preserving patient safety is driving the market's expansion. In clinical trials, for instance, the FDA's Real-World Evidence (RWE) program promotes the use of real-world data, which can lead to more efficient research designs and quicker approvals.
Impact of COVID-19 on Global Positron Emission Tomography (PET) Scanner Market
The Positron Emission Tomography (PET) scanner market is hampered by a number of factors from growing and being widely utilized. One of the primary barriers that keeps many healthcare facilities, especially those in developing countries, from having access to PET scanners is their high cost and maintenance requirements. It is difficult to properly stock and administer the radiotracers required for imaging since they are costly and have a short shelf life. The cost of purchasing the scanners themselves is likewise high. The need for specialist facilities to handle and build these radiotracers adds even more logistical complexity.
Positron Emission Tomography (PET) Scanner Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as: Canon Medical Systems, GE Healthcare, Kindsway Biotech, Koninklijke Philips N.V., Mediso Ltd., PerkinElmer, Positron, Shimadzu Corporation, and Siemens Healthineers AG.
Global Positron Emission Tomography (PET) Scanner Market Segmentation:
By Modality: Based on the Modality, Global Positron Emission Tomography (PET) Scanner Market is segmented as; PET-CT, PET-MRI.
By Application: Based on the Application, Global Positron Emission Tomography (PET) Scanner Market is segmented as; Oncology, Cardiology, Neurology.
By End User: Based on the End User, Global Positron Emission Tomography (PET) Scanner Market is segmented as; Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes.
By Region: This research also include data for North America, Europe, Asia-Pacific Middle East & Africa and South America.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.